Teva Pharmaceuticals USA, Inc recalls Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton con
Recalled February 21, 2024 · FDA recall D-0322-2024 · Teva Pharmaceuticals USA
Hazard
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. · FDA Class III
Units
19,824 cartons
Sold at
nationwide
Description
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Product
Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →